The memorandum establishes a framework for a long-term partnership aimed at connecting research with the needs of the patient community. Both parties will combine their expertise in an effort to support the development of precision medicine and improve care for individuals with rare diseases. The collaboration will also include the exchange of expert knowledge, information sharing, and joint educational initiatives focused on supporting both patients and healthcare professionals.